Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1966 May;21(3):215–219. doi: 10.1136/thx.21.3.215

Changes in the fibrinolytic system components during extracorporeal circulation.

K Kamel, S H Davies, R A Cumming
PMCID: PMC1019028  PMID: 5914993

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOZZO A., PIOMELLI S., SCHETTINI F. Titolazione del potere antifibrinolitico del siero umano: descrizione di una nuova metodica. Riv Ist Sieroter Ital. 1956 Jul-Aug;31(4):362–367. [PubMed] [Google Scholar]
  2. BROWN I. W., Jr, SMITH W. W. Hematologic problems associated with the use of extracorporeal circulation for cardiovascular surgery. Ann Intern Med. 1958 Nov;49(5):1035–1048. doi: 10.7326/0003-4819-49-5-1035. [DOI] [PubMed] [Google Scholar]
  3. COOLEY D. A., BELMONTE B. A., DE BAKEY M. E., LATSON J. R. Temporary extracorporeal circulation in the surgical treatment of cardiac and aortic disease; report of 98 cases. Ann Surg. 1957 Jun;145(6):898-912; discussions, 913-4. doi: 10.1097/00000658-195706000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CUMMING R. A., DAVIES S. H., KAMEL K., MACKENZIE G. J., MASSON A., WADE J. D. SOME HAEMATOLOGICAL OBSERVATIONS IN CARDIOPULMONARY BYPASS AT NORMOTHERMIA USING THE MELROSE OXYGENATOR. Thorax. 1964 Mar;19:170–175. doi: 10.1136/thx.19.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DEWALL R. A., LONG D. M., GEMMILL S. J., LILLEHEI C. W. Certain blood changes in patients undergoing extracorporeal circulation; analysis of 350 perfusions. J Thorac Surg. 1959 Mar;37(3):325–333. [PubMed] [Google Scholar]
  6. GANS H., LILLEHEI C. W., KRIVIT W. Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator. Ann Surg. 1961 Dec;154:915–924. [PMC free article] [PubMed] [Google Scholar]
  7. GERBODE F., HURT R., MACKENZIE R., OSBORN J. J., PERKINS H., SHAW A. Cause and prevention of hemorrhage following extracorporeal circulation. Surg Forum. 1956;6:96–100. [PubMed] [Google Scholar]
  8. GIBBON J. H., Jr Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954 Mar;37(3):171–passim. [PubMed] [Google Scholar]
  9. HOLEMANS R., VERMYLEN C., VERSTRAETE M. [Experimental studies on some problems of blood coagulation with reference to extracorporeal circulation]. Med Exp Int J Exp Med. 1960;2:294–302. [PubMed] [Google Scholar]
  10. MACKENZIE G. J., DAVIES S. H., MASSON H. B., WADE J. D. CAUSES OF METABOLIC ACIDOSIS IN EXTRACORPOREAL CIRCULATION AT NORMOTHERMIA. Thorax. 1963 Sep;18:215–219. doi: 10.1136/thx.18.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MATZKE J., JENSEN R. S., RYGG I. H. Blood clotting problems in extracorporeal circulation. Acta Chir Scand. 1961 Oct;122:208–216. [PubMed] [Google Scholar]
  12. NILSSON I. M., OLOW B. Determination of fibrinogen and fibrinogenolytic activity. Thromb Diath Haemorrh. 1962 Nov 15;8:297–310. [PubMed] [Google Scholar]
  13. PERKINS H. A., OSBORN J. J., HURT R., GERBODE F. Neutralization of heparin in vivo with protamine; a simple method of estimating the required dose. J Lab Clin Med. 1956 Aug;48(2):223–226. [PubMed] [Google Scholar]
  14. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]
  15. SANDBERG H., TSITOURIS G., BELLET S. Experiences with inhibitors to the plasmin-plasminogen system in the human subject: their modifications by thrombolysin therapy. Am J Cardiol. 1960 Aug;6:432–438. doi: 10.1016/0002-9149(60)90336-2. [DOI] [PubMed] [Google Scholar]
  16. SAWYER W. D., FLETCHER A. P., ALKJAERSIN N., SHERRY S. Studies on the thrombolytic activity of human plasma. J Clin Invest. 1960 Feb;39:426–434. doi: 10.1172/JCI104054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. VON KAULLA K. N. Intravenous protein-free pyrogen; a powerful fibrinolytic agent in man. Circulation. 1958 Feb;17(2):187–198. doi: 10.1161/01.cir.17.2.187. [DOI] [PubMed] [Google Scholar]
  18. VON KAULLA K. N., McDONALD T. S. The effect of heparin on components of the human fibrinolytic system. Blood. 1958 Aug;13(8):811–821. [PubMed] [Google Scholar]
  19. VON KAULLA K. N., SWAN H. Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant. J Thorac Surg. 1958 Oct;36(4):519–530. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES